Skip to main content
. 2020 Jul 21;80(13):1267–1292. doi: 10.1007/s40265-020-01367-z
COVID-19 is a syndrome of viral replication and a host inflammatory response.
Tackling the immune response may be as important as addressing viral replication.
Specific and non-specific immune modulators have the potential to inhibit cytokines and quell the cytokine storm.